Inhibition of tumour necrosis factor-α in patients with chronic hepatitis C infection

被引：0
|
作者：
C. Zavos
J. Kountouras
N. Zavos
D. Chatzopoulos
机构：
[1] Aristotle University of Thessaloniki,Department of Gastroenterology, Second Medical Clinic
[2] Ippokration Hospital,undefined
来源：
Clinical Rheumatology | 2007年 / 26卷
关键词：
Chronic Hepatitis; Spondylitis; Psoriatic Arthritis; Alanine Transaminase; Viral Reactivation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：283 / 283
相关论文
共 50 条
  • [31] Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection
    LJ Yee
    J Tang
    J Herrera
    RA Kaslow
    DJ van Leeuwen
    Genes & Immunity, 2000, 1 : 386 - 390
  • [32] The tumour necrosis factor-α-238A allele increases the risk of chronic HBV infection in European populations
    Zheng, M. -H.
    Xiao, D. -D.
    Lin, X. -F.
    Wu, S. -J.
    Peng, M. -M.
    Yu, X. -Y.
    Liu, W. -Y.
    Li, L. -F.
    Shi, K. -Q.
    Fan, Y. -C.
    Chen, Y. -P.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 (02) : E11 - E17
  • [33] Endometriosis is sustained by tumour necrosis factor-α
    Bullimore, DW
    MEDICAL HYPOTHESES, 2003, 60 (01) : 84 - 88
  • [34] Safety of tumour necrosis factor-α antagonists
    Khanna, D
    McMahon, M
    Furst, DE
    DRUG SAFETY, 2004, 27 (05) : 307 - 324
  • [35] Safety of Tumour Necrosis Factor-α Antagonists
    Dinesh Khanna
    Maureen McMahon
    Daniel E. Furst
    Drug Safety, 2004, 27 : 307 - 324
  • [36] Tumour necrosis factor-α is a foe for patients with acute myocardial infarction
    Shi, Kai-Hu
    Tao, Hui
    Wu, Jun-Xu
    HEART, 2014, 100 (02) : 180 - 181
  • [37] Polymorphisms in the interleukin-10, tumor necrosis factor-α, and transforming growth factor-β1 genes in chronic hepatitis C patients treated with interferon and ribavirin
    Vidigal, PG
    Germer, JJ
    Zein, NN
    JOURNAL OF HEPATOLOGY, 2002, 36 (02) : 271 - 277
  • [38] Is universal screening for hepatitis C infection prior to commencing antitumour necrosis factor-α therapy necessary?
    Reid, C. T.
    De Gascun, C.
    Hall, W.
    Collins, P.
    Lally, A.
    Kirby, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (06) : 1319 - 1321
  • [39] Serum tumour necrosis factor-α and soluble tumour necrosis factor receptors levels in patients with Guillain-Barre syndrome
    Radhakrishnan, VV
    Sumi, MG
    Reuben, S
    Mathai, A
    Nair, MD
    ACTA NEUROLOGICA SCANDINAVICA, 2004, 109 (01): : 71 - 74
  • [40] A comparison of safety profiles of tumour necrosis factor α inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C
    Chen, Yi-Ming
    Chen, Hsin-Hua
    Chen, Yi-Hsing
    Hsieh, Tsu-Yi
    Hsieh, Chia-Wei
    Hung, Wei-Ting
    Lan, Joung-Liang
    Chen, Der-Yuan
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (03) : 626 - 627
12345